I agree, a few months ago they made shareholders dip into their pockets to pay 0.21 per share to fund all necessary trials to get this product to market. Shares are now around .05. and shareholders have been told the company doesn't have enough money to complete the necessary trials. Everyone has been eagerly awaiting news of partnerships or funding agreements but we get an announcement saying they are going back into a commercial relationship with QUT?! I am beyond frustrated with this company!
Research, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
